A hybrid biomimetic nanomatrix composed of electrospun polycaprolactone and bioactive peptide amphiphiles for cardiovascular implants

Adinarayana Andukuri, Meenakshi Kushwaha, Ajay Tambralli, Joel M. Anderson, Derrick R. Dean, Joel L. Berry, Young Doug Sohn, Young Sup Yoon, Brigitta C. Brott, Ho Wook Jun

Research output: Contribution to journalArticlepeer-review

70 Citations (Scopus)


Current cardiovascular therapies are limited by the loss of endothelium, restenosis and thrombosis. The goal of this study was to develop a biomimetic hybrid nanomatrix that combined the unique properties of electrospun polycaprolactone (ePCL) nanofibers with self-assembled peptide amphiphiles (PAs). ePCL nanofibers have interconnected nanoporous structures, but are hampered by a lack of surface bioactivity to control cellular behavior. It has been hypothesized that PAs could self-assemble onto the surface of ePCL nanofibers and endow them with the characteristic properties of native endothelium. The PAs, which comprised hydrophobic alkyl tails attached to functional hydrophilic peptide sequences, contained enzyme-mediated degradable sites coupled to either endothelial cell-adhesive ligands (YIGSR) or polylysine (KKKKK) nitric oxide (NO) donors. Two different PAs (PA-YIGSR and PA-KKKKK) were successfully synthesized and mixed in a 90:10 (YK) ratio to obtain PA-YK. PA-YK was reacted with pure NO to develop PA-YK-NO, which was then self-assembled onto ePCL nanofibers to generate a hybrid nanomatrix, ePCL-PA-YK-NO. Uniform coating of self-assembled PA nanofibers on ePCL was confirmed by transmission electron microscopy. Successful NO release from ePCL-PA-YK-NO was observed. ePCL-YK and ePCL-PA-YK-NO showed significantly increased adhesion of human umbilical vein endothelial cells (HUVECs). ePCL-PA-YK-NO also showed significantly increased proliferation of HUVECs and reduced smooth muscle cell proliferation. ePCL-PA-YK-NO also displayed significantly reduced platelet adhesion compared with ePCL, ePCL-PA-YK and a collagen control. These results indicate that this hybrid nanomatrix has great potential application in cardiovascular implants.

Original languageEnglish
Pages (from-to)225-233
Number of pages9
JournalActa Biomaterialia
Issue number1
Publication statusPublished - 2011 Jan

Bibliographical note

Funding Information:
The authors express their gratitude to Melissa Chimento for use of the High Resolution Imaging facility and Dr Robin G. Foley for use of the Scanning Electron Microscopic facility. This study was supported by the Wallace H. Coulter Foundation and a NSF Career Award (CBET-0952974) (H.W.J.), a Caroline P. Ireland Research Scholarship (A.A. and M.K.), a AHA Greater Southeast Affiliate Predoctoral Fellowship (10PRE3500024) (A.A.), a NIH T32 Predoctoral Training Grant (NIBIB EB004312-01 ) and a Ruth L. Kirschstein National Research Service Award Individual Fellowship ( 1F31DE021286-01 ) (J.M.A.).

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Biomaterials
  • Biochemistry
  • Biomedical Engineering
  • Molecular Biology


Dive into the research topics of 'A hybrid biomimetic nanomatrix composed of electrospun polycaprolactone and bioactive peptide amphiphiles for cardiovascular implants'. Together they form a unique fingerprint.

Cite this